Evaluating the risk factors for developing resistance to parenteral therapy for tubo-ovarian abscess: A case-control study

Aim The aim of this study was to identify factors that can predict the resistance to parenteral therapy in patients with tubo‐ovarian abscesses (TOA). Material and Methods We conducted a case–control study involving 55 admitted patients with TOA. The subjects eligible for this study included 28 pati...

Full description

Saved in:
Bibliographic Details
Published inThe journal of obstetrics and gynaecology research Vol. 39; no. 5; pp. 1019 - 1023
Main Authors Mizushima, Taichi, Yoshida, Hiroshi, Ohi, Yuka, Ishikawa, Masahiko, Hirahara, Fumiki
Format Journal Article
LanguageEnglish
Published Australia Blackwell Publishing Ltd 01.05.2013
Subjects
Online AccessGet full text
ISSN1341-8076
1447-0756
1447-0756
DOI10.1111/jog.12018

Cover

Abstract Aim The aim of this study was to identify factors that can predict the resistance to parenteral therapy in patients with tubo‐ovarian abscesses (TOA). Material and Methods We conducted a case–control study involving 55 admitted patients with TOA. The subjects eligible for this study included 28 patients who failed antibiotic therapy and required surgery (surgical cases) and 27 patients who were conservatively cured (control cases). The clinical characteristics of the patients on admission were reviewed. Logistic regression analysis was performed after univariate analysis to identify potentially important variables and to calculate odds ratios with 95% confidence intervals. Results As per the univariate analysis, compared to the control cases, the surgical cases were older (40.4 vs 31.5 years), had higher white blood cell counts (14000 vs 11828 cells/mm3), higher C‐reactive protein levels (16.1 vs 7.6 mg/dL), and a larger abscess diameter (6.6 vs 3.9 cm). There were no significant differences in gravidity, parity, body temperature, rate of endometrial cyst formation, and Chlamydia trachomatis infection rates between the groups. Multiple logistic regression analysis indicated that the only statistically significant risk factor predicting parenteral antibiotic therapy failure was the abscess diameter >5 cm (odds ratio = 69.6; 95% confidence interval = 9.3–527, P < 0.0001). Conclusion An abscess diameter >5 cm is an important factor for predicting the failure of antibiotic therapy in patients with TOA. Moreover, it is useful for determining whether patients with TOA should be surgically treated.
AbstractList Aim The aim of this study was to identify factors that can predict the resistance to parenteral therapy in patients with tubo‐ovarian abscesses (TOA). Material and Methods We conducted a case–control study involving 55 admitted patients with TOA. The subjects eligible for this study included 28 patients who failed antibiotic therapy and required surgery (surgical cases) and 27 patients who were conservatively cured (control cases). The clinical characteristics of the patients on admission were reviewed. Logistic regression analysis was performed after univariate analysis to identify potentially important variables and to calculate odds ratios with 95% confidence intervals. Results As per the univariate analysis, compared to the control cases, the surgical cases were older (40.4 vs 31.5 years), had higher white blood cell counts (14000 vs 11828 cells/mm3), higher C‐reactive protein levels (16.1 vs 7.6 mg/dL), and a larger abscess diameter (6.6 vs 3.9 cm). There were no significant differences in gravidity, parity, body temperature, rate of endometrial cyst formation, and Chlamydia trachomatis infection rates between the groups. Multiple logistic regression analysis indicated that the only statistically significant risk factor predicting parenteral antibiotic therapy failure was the abscess diameter >5 cm (odds ratio = 69.6; 95% confidence interval = 9.3–527, P < 0.0001). Conclusion An abscess diameter >5 cm is an important factor for predicting the failure of antibiotic therapy in patients with TOA. Moreover, it is useful for determining whether patients with TOA should be surgically treated.
The aim of this study was to identify factors that can predict the resistance to parenteral therapy in patients with tubo-ovarian abscesses (TOA).AIMThe aim of this study was to identify factors that can predict the resistance to parenteral therapy in patients with tubo-ovarian abscesses (TOA).We conducted a case-control study involving 55 admitted patients with TOA. The subjects eligible for this study included 28 patients who failed antibiotic therapy and required surgery (surgical cases) and 27 patients who were conservatively cured (control cases). The clinical characteristics of the patients on admission were reviewed. Logistic regression analysis was performed after univariate analysis to identify potentially important variables and to calculate odds ratios with 95% confidence intervals.MATERIAL AND METHODSWe conducted a case-control study involving 55 admitted patients with TOA. The subjects eligible for this study included 28 patients who failed antibiotic therapy and required surgery (surgical cases) and 27 patients who were conservatively cured (control cases). The clinical characteristics of the patients on admission were reviewed. Logistic regression analysis was performed after univariate analysis to identify potentially important variables and to calculate odds ratios with 95% confidence intervals.As per the univariate analysis, compared to the control cases, the surgical cases were older (40.4 vs 31.5 years), had higher white blood cell counts (14000 vs 11828 cells/mm³), higher C-reactive protein levels (16.1 vs 7.6 mg/dL), and a larger abscess diameter (6.6 vs 3.9 cm). There were no significant differences in gravidity, parity, body temperature, rate of endometrial cyst formation, and Chlamydia trachomatis infection rates between the groups. Multiple logistic regression analysis indicated that the only statistically significant risk factor predicting parenteral antibiotic therapy failure was the abscess diameter >5 cm (odds ratio = 69.6; 95% confidence interval = 9.3-527, P < 0.0001).RESULTSAs per the univariate analysis, compared to the control cases, the surgical cases were older (40.4 vs 31.5 years), had higher white blood cell counts (14000 vs 11828 cells/mm³), higher C-reactive protein levels (16.1 vs 7.6 mg/dL), and a larger abscess diameter (6.6 vs 3.9 cm). There were no significant differences in gravidity, parity, body temperature, rate of endometrial cyst formation, and Chlamydia trachomatis infection rates between the groups. Multiple logistic regression analysis indicated that the only statistically significant risk factor predicting parenteral antibiotic therapy failure was the abscess diameter >5 cm (odds ratio = 69.6; 95% confidence interval = 9.3-527, P < 0.0001).An abscess diameter >5 cm is an important factor for predicting the failure of antibiotic therapy in patients with TOA. Moreover, it is useful for determining whether patients with TOA should be surgically treated.CONCLUSIONAn abscess diameter >5 cm is an important factor for predicting the failure of antibiotic therapy in patients with TOA. Moreover, it is useful for determining whether patients with TOA should be surgically treated.
The aim of this study was to identify factors that can predict the resistance to parenteral therapy in patients with tubo-ovarian abscesses (TOA). We conducted a case-control study involving 55 admitted patients with TOA. The subjects eligible for this study included 28 patients who failed antibiotic therapy and required surgery (surgical cases) and 27 patients who were conservatively cured (control cases). The clinical characteristics of the patients on admission were reviewed. Logistic regression analysis was performed after univariate analysis to identify potentially important variables and to calculate odds ratios with 95% confidence intervals. As per the univariate analysis, compared to the control cases, the surgical cases were older (40.4 vs 31.5 years), had higher white blood cell counts (14000 vs 11828 cells/mm³), higher C-reactive protein levels (16.1 vs 7.6 mg/dL), and a larger abscess diameter (6.6 vs 3.9 cm). There were no significant differences in gravidity, parity, body temperature, rate of endometrial cyst formation, and Chlamydia trachomatis infection rates between the groups. Multiple logistic regression analysis indicated that the only statistically significant risk factor predicting parenteral antibiotic therapy failure was the abscess diameter >5 cm (odds ratio = 69.6; 95% confidence interval = 9.3-527, P < 0.0001). An abscess diameter >5 cm is an important factor for predicting the failure of antibiotic therapy in patients with TOA. Moreover, it is useful for determining whether patients with TOA should be surgically treated.
Author Ishikawa, Masahiko
Hirahara, Fumiki
Yoshida, Hiroshi
Mizushima, Taichi
Ohi, Yuka
Author_xml – sequence: 1
  givenname: Taichi
  surname: Mizushima
  fullname: Mizushima, Taichi
  email: mizusima@yokohama-cu.ac.jp
  organization: Department of Gynecology, Yokohama City University Medical Center, Kanagawa, Yokohama, Japan
– sequence: 2
  givenname: Hiroshi
  surname: Yoshida
  fullname: Yoshida, Hiroshi
  organization: Department of Gynecology, Yokohama City University Medical Center, Kanagawa, Yokohama, Japan
– sequence: 3
  givenname: Yuka
  surname: Ohi
  fullname: Ohi, Yuka
  organization: Department of Gynecology, Yokohama City University Medical Center, Kanagawa, Yokohama, Japan
– sequence: 4
  givenname: Masahiko
  surname: Ishikawa
  fullname: Ishikawa, Masahiko
  organization: Department of Gynecology, Yokohama City University Medical Center, Kanagawa, Yokohama, Japan
– sequence: 5
  givenname: Fumiki
  surname: Hirahara
  fullname: Hirahara, Fumiki
  organization: Department of Obstetrics and Gynecology, Yokohama City University School of Medicine, Kanagawa, Yokohama, Japan
BackLink https://www.ncbi.nlm.nih.gov/pubmed/23509912$$D View this record in MEDLINE/PubMed
BookMark eNp1kc1u1DAUhS1URH9gwQsgL2GRNo7t2MOuGspAVVEJ8bO0bpyb4jYTB9sZmD59PZ0ZFgi8sSV_35V9zjE5GPyAhLxk5SnL6-zW35yyqmT6CTliQqiiVLI-yGcuWKFLVR-S4xhvy5KpGdPPyGHFZTmbseqI3F-soJ8gueGGph9Ig4t3tAObfIi084G2uMLej5v7gNHFBINFmjwdIeCQMEC_EQOM60c-TY0v_AqCg4FCEy3G-JaeUwsRC-uHFHxPY5ra9XPytIM-4ovdfkK-vr_4Mv9QXF0vPs7PrworJNdFVWuJ2rYKVds2bccVdCgFyq5RVnDJBDChG9FwYBqZrJkSGivLrGBgueAn5PV27hj8zwljMkuXn9X3MKCfoskp1VJXSrKMvtqhU7PE1ozBLSGszT6vDJxtARt8jAE7Y13K6W3-Ba43rDSbRkxuxDw2ko03fxn7of9id9N_uR7X_wfN5fVibxRbIxeDv_8YEO5MrbiS5vunhZl9frf4dimUmfMH46yrSw
CitedBy_id crossref_primary_10_5180_jsgoe_31_166
crossref_primary_10_1016_j_jogoh_2020_101983
crossref_primary_10_1080_01443615_2017_1405927
crossref_primary_10_5180_jsgoe_39_2_34
crossref_primary_10_1186_s40792_015_0069_6
crossref_primary_10_3109_01443615_2014_991294
crossref_primary_10_1016_j_ijgo_2016_04_006
crossref_primary_10_1016_j_idcr_2025_e02184
crossref_primary_10_1159_000381772
crossref_primary_10_1016_j_ejogrb_2021_01_011
crossref_primary_10_1111_jog_15870
crossref_primary_10_1016_j_ejogrb_2019_05_004
crossref_primary_10_3892_etm_2019_7699
Cites_doi 10.1097/00003081-196903000-00015
10.1016/0002-9378(56)90174-0
10.1002/(SICI)1098-0997(2000)8:2<88::AID-IDOG5>3.0.CO;2-X
10.1016/S0015-0282(16)58088-1
10.1093/clinids/5.5.876
10.1111/j.0001-6349.2005.00509.x
10.1016/0002-9378(85)90392-8
10.1016/0002-9378(64)90604-0
10.1016/j.ejogrb.2003.10.032
10.2214/ajr.158.3.1738998
10.1097/00003081-199306000-00022
10.1016/S0001-2998(88)80041-2
10.1016/j.ajog.2005.06.019
10.1046/j.1469-0705.1998.12010056.x
10.1097/OGX.0b013e3181b8b0d6
10.1016/j.fertnstert.2004.01.032
10.1016/S0002-9378(98)70333-3
10.1016/0002-9378(80)91107-2
10.1111/j.1447-0756.1997.tb00867.x
ContentType Journal Article
Copyright 2013 The Authors. Journal of Obstetrics and Gynaecology Research © 2013 Japan Society of Obstetrics and Gynecology
2013 The Authors. Journal of Obstetrics and Gynaecology Research © 2013 Japan Society of Obstetrics and Gynecology.
Copyright_xml – notice: 2013 The Authors. Journal of Obstetrics and Gynaecology Research © 2013 Japan Society of Obstetrics and Gynecology
– notice: 2013 The Authors. Journal of Obstetrics and Gynaecology Research © 2013 Japan Society of Obstetrics and Gynecology.
DBID BSCLL
AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7X8
DOI 10.1111/jog.12018
DatabaseName Istex
CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
MEDLINE - Academic
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
MEDLINE - Academic
DatabaseTitleList
MEDLINE - Academic
MEDLINE
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1447-0756
EndPage 1023
ExternalDocumentID 23509912
10_1111_jog_12018
JOG12018
ark_67375_WNG_9RDGVJ47_C
Genre article
Journal Article
GeographicLocations Japan
GeographicLocations_xml – name: Japan
GroupedDBID ---
.3N
.55
.GA
.Y3
05W
0R~
10A
1OB
1OC
29L
31~
33P
36B
3SF
4.4
50Y
50Z
51W
51X
52M
52N
52O
52P
52R
52S
52T
52U
52V
52W
52X
53G
5GY
5HH
5LA
5VS
66C
702
7PT
8-0
8-1
8-3
8-4
8-5
8UM
930
A01
A03
AAESR
AAEVG
AAHHS
AANLZ
AAONW
AASGY
AAWTL
AAXRX
AAZKR
ABCQN
ABCUV
ABEML
ABPVW
ABQWH
ABXGK
ACAHQ
ACBWZ
ACCFJ
ACCZN
ACGFS
ACGOF
ACMXC
ACPOU
ACPRK
ACSCC
ACXBN
ACXQS
ADBBV
ADBTR
ADEOM
ADIZJ
ADKYN
ADMGS
ADOZA
ADXAS
ADZMN
AEEZP
AEIGN
AEIMD
AENEX
AEQDE
AEUQT
AEUYR
AFBPY
AFEBI
AFFPM
AFGKR
AFPWT
AFZJQ
AHBTC
AIACR
AITYG
AIURR
AIWBW
AJBDE
ALAGY
ALMA_UNASSIGNED_HOLDINGS
ALUQN
AMBMR
AMYDB
ATUGU
AZBYB
AZFZN
AZVAB
BAFTC
BDRZF
BFHJK
BHBCM
BMXJE
BROTX
BRXPI
BSCLL
BY8
C45
CAG
COF
CS3
D-6
D-7
D-E
D-F
DCZOG
DPXWK
DR2
DRFUL
DRMAN
DRSTM
DU5
DUUFO
EBS
EJD
EMOBN
ESX
EX3
F00
F01
F04
F5P
FEDTE
FUBAC
G-S
G.N
GODZA
H.X
HF~
HGLYW
HVGLF
HZI
HZ~
IHE
IX1
J0M
K48
KBYEO
LATKE
LC2
LC3
LEEKS
LH4
LITHE
LOXES
LP6
LP7
LUTES
LW6
LYRES
MEWTI
MK4
MRFUL
MRMAN
MRSTM
MSFUL
MSMAN
MSSTM
MXFUL
MXMAN
MXSTM
N04
N05
N9A
NF~
O66
O9-
OIG
OVD
P2P
P2W
P2X
P2Z
P4B
P4D
PALCI
PQQKQ
Q.N
Q11
QB0
R.K
RIWAO
RJQFR
ROL
RX1
SAMSI
SUPJJ
TEORI
UB1
W8V
W99
WBKPD
WHWMO
WIH
WIJ
WIK
WOHZO
WOW
WQJ
WRC
WVDHM
WXI
WXSBR
X7M
XG1
ZZTAW
~IA
~WT
AAHQN
AAIPD
AAMMB
AAMNL
AANHP
AAYCA
ACRPL
ACYXJ
ADNMO
AEFGJ
AEYWJ
AFWVQ
AGHNM
AGQPQ
AGXDD
AGYGG
AIDQK
AIDYY
ALVPJ
AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7X8
ID FETCH-LOGICAL-c4538-2685e8cd7e7ddbdf37afe54e5fb7c43514a148b4b3a18e1561748e2c1c41ac343
IEDL.DBID DR2
ISSN 1341-8076
1447-0756
IngestDate Fri Jul 11 01:41:01 EDT 2025
Mon Jul 21 05:14:15 EDT 2025
Tue Jul 01 02:30:35 EDT 2025
Thu Apr 24 22:57:17 EDT 2025
Tue Sep 09 05:12:22 EDT 2025
Wed Oct 30 09:49:28 EDT 2024
IsPeerReviewed true
IsScholarly true
Issue 5
Language English
License http://onlinelibrary.wiley.com/termsAndConditions#vor
2013 The Authors. Journal of Obstetrics and Gynaecology Research © 2013 Japan Society of Obstetrics and Gynecology.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c4538-2685e8cd7e7ddbdf37afe54e5fb7c43514a148b4b3a18e1561748e2c1c41ac343
Notes istex:8240D928E3DC051A1CA57C35B0A94FE17432D0EC
ArticleID:JOG12018
ark:/67375/WNG-9RDGVJ47-C
ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
PMID 23509912
PQID 1346582751
PQPubID 23479
PageCount 5
ParticipantIDs proquest_miscellaneous_1346582751
pubmed_primary_23509912
crossref_citationtrail_10_1111_jog_12018
crossref_primary_10_1111_jog_12018
wiley_primary_10_1111_jog_12018_JOG12018
istex_primary_ark_67375_WNG_9RDGVJ47_C
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate May 2013
PublicationDateYYYYMMDD 2013-05-01
PublicationDate_xml – month: 05
  year: 2013
  text: May 2013
PublicationDecade 2010
PublicationPlace Australia
PublicationPlace_xml – name: Australia
PublicationTitle The journal of obstetrics and gynaecology research
PublicationTitleAlternate J Obstet Gynaecol Res
PublicationYear 2013
Publisher Blackwell Publishing Ltd
Publisher_xml – name: Blackwell Publishing Ltd
References Timor-Tritsch IE, Lerner JP, Monteagudo A, Murphy KE, Heller DS. Transvaginal sonographic markers of tubal inflammatory disease. Ultrasound Obstet Gynecol 1998; 12: 56-66.
Chen MJ, Yang JH, Yang YS, Ho HN. Increased occurrence of tubo-ovarian abscesses in women with stage III and IV endometriosis. Fertil Steril 2004; 82: 498-499.
Sørbye IK, Jerve F, Staff AC. Reduction in hospitalized women with pelvic inflammatory disease in Oslo over the past decade. Acta Obstet Gynecol Scand 2005; 84: 290-296.
Cerha HT, Collins CG, Nix FJ. Ruptured tuboovarian abscess. Am J Obstet Gynecol 1956; 72: 820-829.
Ginsburg DS, Stern JL, Hamod KA, Genadry R, Spence MR. Tubo-ovarian abscess: A retrospective review. Am J Obstet Gynecol 1980; 138: 1055-1058.
Gjelland K, Ekerhovd E, Granberg S. Transvaginal ultrasound-guided aspiration for treatment of tubo-ovarian abscess: A study of 302 cases. Am J Obstet Gynecol 2005; 193: 1323-1330.
Wiesenfeld HC, Sweet RL. Progress in the management of tuboovarian abscesses. Clin Obstet Gynecol 1993; 36: 433-444.
McNeeley SG, Hendrix SL, Mazzoni MM, Kmak DC, Ransom SB. Medically sound, cost-effective treatment for pelvic inflammatory disease and tuboovarian abscess. Am J Obstet Gynecol 1998; 178: 1272-1278.
Guerriero S, Mais V, Ajossa S, Paoletti AM, Angiolucci M, Melis GB. Transvaginal ultrasonography combined with CA-125 plasma levels in the diagnosis of endometrioma. Fertil Steril 1996; 65: 293-298.
Landers DV, Sweet RL. Tubo-ovarian abscess: Contemporary approach to management. Rev Infect Dis 1983; 5: 876-884.
Protopapas AG, Diakomanolis ES, Milingos SD et al. Tubo-ovarian abscesses in postmenopausal women: Gynecological malignancy until proven otherwise? Eur J Obstet Gynecol Reprod Biol 2004; 114: 203-209.
Jamieson DJ, Duerr A, Macasaet MA, Peterson HB, Hillis SD. Risk factors for a complicated clinical course among women hospitalized with pelvic inflammatory disease. Infect Dis Obstet Gynecol 2000; 8: 88-93.
Centers for Disease Control and Prevention. 1998 guidelines for treatment of sexually transmitted diseases. Centers for Disease Control and Prevention. MMWR Recomm Rep 1998; 47 (RR-1): 1-111.
Hager WD, Eschenbach DA, Spence MR, Sweet RL. Criteria for diagnosis and grading of salpingitis. Obstet Gynecol 1983; 61: 113-114.
Pedowitz P, Bloomfield RD. Ruptured adnexal abscess (Tuboovarian) with generalized peritonitis. Am J Obstet Gynecol 1964; 88: 721-729.
Wilbur AC, Aizenstein RI, Napp TE. CT findings in tuboovarian abscess. AJR Am J Roentgenol 1992; 158: 575-579.
Mickal A, Sellmann AH. Management of tubo-ovarian abscess. Clin Obstet Gynecol 1969; 12: 252-264.
Rosen M, Breitkopf D, Waud K. Tubo-ovarian abscess management options for women who desire fertility. Obstet Gynecol Surv 2009; 64: 681-689.
Landers DV, Sweet RL. Current trends in the diagnosis and treatment of tuboovarian abscess. Am J Obstet Gynecol 1985; 151: 1098-1110.
Kubota T, Ishi K, Takeuchi H. A study of tubo-ovarian and ovarian abscesses, with a focus on cases with endometrioma. J Obstet Gynaecol Res 1997; 23: 421-426.
Gagliardi PD, Hoffer PB, Rosenfield AT. Correlative imaging in abdominal infection: An algorithmic approach using nuclear medicine, ultrasound, and computed tomography. Semin Nucl Med 1988; 18: 320-334.
1993; 36
1980; 138
2005; 193
2004; 114
2004; 82
2009; 64
1956; 72
1988; 18
2000; 8
1992; 158
1983; 5
1997; 23
1969; 12
2005; 84
1964; 88
1983; 61
1998; 178
1985; 151
1998; 12
1996; 65
1998; 47
(e_1_2_6_6_1) 1998; 47
e_1_2_6_21_1
e_1_2_6_20_1
Hager WD (e_1_2_6_10_1) 1983; 61
e_1_2_6_9_1
e_1_2_6_8_1
e_1_2_6_19_1
e_1_2_6_5_1
Cerha HT (e_1_2_6_3_1) 1956; 72
e_1_2_6_4_1
e_1_2_6_7_1
e_1_2_6_13_1
e_1_2_6_14_1
e_1_2_6_11_1
e_1_2_6_2_1
e_1_2_6_12_1
e_1_2_6_22_1
e_1_2_6_17_1
e_1_2_6_18_1
e_1_2_6_15_1
e_1_2_6_16_1
References_xml – reference: Chen MJ, Yang JH, Yang YS, Ho HN. Increased occurrence of tubo-ovarian abscesses in women with stage III and IV endometriosis. Fertil Steril 2004; 82: 498-499.
– reference: Mickal A, Sellmann AH. Management of tubo-ovarian abscess. Clin Obstet Gynecol 1969; 12: 252-264.
– reference: Centers for Disease Control and Prevention. 1998 guidelines for treatment of sexually transmitted diseases. Centers for Disease Control and Prevention. MMWR Recomm Rep 1998; 47 (RR-1): 1-111.
– reference: Sørbye IK, Jerve F, Staff AC. Reduction in hospitalized women with pelvic inflammatory disease in Oslo over the past decade. Acta Obstet Gynecol Scand 2005; 84: 290-296.
– reference: Wilbur AC, Aizenstein RI, Napp TE. CT findings in tuboovarian abscess. AJR Am J Roentgenol 1992; 158: 575-579.
– reference: Gjelland K, Ekerhovd E, Granberg S. Transvaginal ultrasound-guided aspiration for treatment of tubo-ovarian abscess: A study of 302 cases. Am J Obstet Gynecol 2005; 193: 1323-1330.
– reference: Ginsburg DS, Stern JL, Hamod KA, Genadry R, Spence MR. Tubo-ovarian abscess: A retrospective review. Am J Obstet Gynecol 1980; 138: 1055-1058.
– reference: Jamieson DJ, Duerr A, Macasaet MA, Peterson HB, Hillis SD. Risk factors for a complicated clinical course among women hospitalized with pelvic inflammatory disease. Infect Dis Obstet Gynecol 2000; 8: 88-93.
– reference: Guerriero S, Mais V, Ajossa S, Paoletti AM, Angiolucci M, Melis GB. Transvaginal ultrasonography combined with CA-125 plasma levels in the diagnosis of endometrioma. Fertil Steril 1996; 65: 293-298.
– reference: Gagliardi PD, Hoffer PB, Rosenfield AT. Correlative imaging in abdominal infection: An algorithmic approach using nuclear medicine, ultrasound, and computed tomography. Semin Nucl Med 1988; 18: 320-334.
– reference: Timor-Tritsch IE, Lerner JP, Monteagudo A, Murphy KE, Heller DS. Transvaginal sonographic markers of tubal inflammatory disease. Ultrasound Obstet Gynecol 1998; 12: 56-66.
– reference: Pedowitz P, Bloomfield RD. Ruptured adnexal abscess (Tuboovarian) with generalized peritonitis. Am J Obstet Gynecol 1964; 88: 721-729.
– reference: Rosen M, Breitkopf D, Waud K. Tubo-ovarian abscess management options for women who desire fertility. Obstet Gynecol Surv 2009; 64: 681-689.
– reference: Landers DV, Sweet RL. Tubo-ovarian abscess: Contemporary approach to management. Rev Infect Dis 1983; 5: 876-884.
– reference: Landers DV, Sweet RL. Current trends in the diagnosis and treatment of tuboovarian abscess. Am J Obstet Gynecol 1985; 151: 1098-1110.
– reference: Protopapas AG, Diakomanolis ES, Milingos SD et al. Tubo-ovarian abscesses in postmenopausal women: Gynecological malignancy until proven otherwise? Eur J Obstet Gynecol Reprod Biol 2004; 114: 203-209.
– reference: Cerha HT, Collins CG, Nix FJ. Ruptured tuboovarian abscess. Am J Obstet Gynecol 1956; 72: 820-829.
– reference: McNeeley SG, Hendrix SL, Mazzoni MM, Kmak DC, Ransom SB. Medically sound, cost-effective treatment for pelvic inflammatory disease and tuboovarian abscess. Am J Obstet Gynecol 1998; 178: 1272-1278.
– reference: Hager WD, Eschenbach DA, Spence MR, Sweet RL. Criteria for diagnosis and grading of salpingitis. Obstet Gynecol 1983; 61: 113-114.
– reference: Kubota T, Ishi K, Takeuchi H. A study of tubo-ovarian and ovarian abscesses, with a focus on cases with endometrioma. J Obstet Gynaecol Res 1997; 23: 421-426.
– reference: Wiesenfeld HC, Sweet RL. Progress in the management of tuboovarian abscesses. Clin Obstet Gynecol 1993; 36: 433-444.
– volume: 8
  start-page: 88
  year: 2000
  end-page: 93
  article-title: Risk factors for a complicated clinical course among women hospitalized with pelvic inflammatory disease
  publication-title: Infect Dis Obstet Gynecol
– volume: 5
  start-page: 876
  year: 1983
  end-page: 884
  article-title: Tubo‐ovarian abscess: Contemporary approach to management
  publication-title: Rev Infect Dis
– volume: 12
  start-page: 56
  year: 1998
  end-page: 66
  article-title: Transvaginal sonographic markers of tubal inflammatory disease
  publication-title: Ultrasound Obstet Gynecol
– volume: 88
  start-page: 721
  year: 1964
  end-page: 729
  article-title: Ruptured adnexal abscess (Tuboovarian) with generalized peritonitis
  publication-title: Am J Obstet Gynecol
– volume: 23
  start-page: 421
  year: 1997
  end-page: 426
  article-title: A study of tubo‐ovarian and ovarian abscesses, with a focus on cases with endometrioma
  publication-title: J Obstet Gynaecol Res
– volume: 36
  start-page: 433
  year: 1993
  end-page: 444
  article-title: Progress in the management of tuboovarian abscesses
  publication-title: Clin Obstet Gynecol
– volume: 84
  start-page: 290
  year: 2005
  end-page: 296
  article-title: Reduction in hospitalized women with pelvic inflammatory disease in Oslo over the past decade
  publication-title: Acta Obstet Gynecol Scand
– volume: 64
  start-page: 681
  year: 2009
  end-page: 689
  article-title: Tubo‐ovarian abscess management options for women who desire fertility
  publication-title: Obstet Gynecol Surv
– volume: 82
  start-page: 498
  year: 2004
  end-page: 499
  article-title: Increased occurrence of tubo‐ovarian abscesses in women with stage III and IV endometriosis
  publication-title: Fertil Steril
– volume: 158
  start-page: 575
  year: 1992
  end-page: 579
  article-title: CT findings in tuboovarian abscess
  publication-title: AJR Am J Roentgenol
– volume: 178
  start-page: 1272
  year: 1998
  end-page: 1278
  article-title: Medically sound, cost‐effective treatment for pelvic inflammatory disease and tuboovarian abscess
  publication-title: Am J Obstet Gynecol
– volume: 72
  start-page: 820
  year: 1956
  end-page: 829
  article-title: Ruptured tuboovarian abscess
  publication-title: Am J Obstet Gynecol
– volume: 193
  start-page: 1323
  year: 2005
  end-page: 1330
  article-title: Transvaginal ultrasound‐guided aspiration for treatment of tubo‐ovarian abscess: A study of 302 cases
  publication-title: Am J Obstet Gynecol
– volume: 138
  start-page: 1055
  year: 1980
  end-page: 1058
  article-title: Tubo‐ovarian abscess: A retrospective review
  publication-title: Am J Obstet Gynecol
– volume: 12
  start-page: 252
  year: 1969
  end-page: 264
  article-title: Management of tubo‐ovarian abscess
  publication-title: Clin Obstet Gynecol
– volume: 114
  start-page: 203
  year: 2004
  end-page: 209
  article-title: Tubo‐ovarian abscesses in postmenopausal women: Gynecological malignancy until proven otherwise?
  publication-title: Eur J Obstet Gynecol Reprod Biol
– volume: 61
  start-page: 113
  year: 1983
  end-page: 114
  article-title: Criteria for diagnosis and grading of salpingitis
  publication-title: Obstet Gynecol
– volume: 151
  start-page: 1098
  year: 1985
  end-page: 1110
  article-title: Current trends in the diagnosis and treatment of tuboovarian abscess
  publication-title: Am J Obstet Gynecol
– volume: 47
  start-page: 1
  issue: RR‐1
  year: 1998
  end-page: 111
  article-title: 1998 guidelines for treatment of sexually transmitted diseases. Centers for Disease Control and Prevention
  publication-title: MMWR Recomm Rep
– volume: 18
  start-page: 320
  year: 1988
  end-page: 334
  article-title: Correlative imaging in abdominal infection: An algorithmic approach using nuclear medicine, ultrasound, and computed tomography
  publication-title: Semin Nucl Med
– volume: 65
  start-page: 293
  year: 1996
  end-page: 298
  article-title: Transvaginal ultrasonography combined with CA‐125 plasma levels in the diagnosis of endometrioma
  publication-title: Fertil Steril
– ident: e_1_2_6_5_1
  doi: 10.1097/00003081-196903000-00015
– volume: 72
  start-page: 820
  year: 1956
  ident: e_1_2_6_3_1
  article-title: Ruptured tuboovarian abscess
  publication-title: Am J Obstet Gynecol
  doi: 10.1016/0002-9378(56)90174-0
– ident: e_1_2_6_9_1
  doi: 10.1002/(SICI)1098-0997(2000)8:2<88::AID-IDOG5>3.0.CO;2-X
– ident: e_1_2_6_14_1
  doi: 10.1016/S0015-0282(16)58088-1
– ident: e_1_2_6_18_1
  doi: 10.1093/clinids/5.5.876
– volume: 47
  start-page: 1
  issue: 1
  year: 1998
  ident: e_1_2_6_6_1
  article-title: 1998 guidelines for treatment of sexually transmitted diseases. Centers for Disease Control and Prevention
  publication-title: MMWR Recomm Rep
– volume: 61
  start-page: 113
  year: 1983
  ident: e_1_2_6_10_1
  article-title: Criteria for diagnosis and grading of salpingitis
  publication-title: Obstet Gynecol
– ident: e_1_2_6_15_1
  doi: 10.1111/j.0001-6349.2005.00509.x
– ident: e_1_2_6_8_1
  doi: 10.1016/0002-9378(85)90392-8
– ident: e_1_2_6_4_1
  doi: 10.1016/0002-9378(64)90604-0
– ident: e_1_2_6_21_1
  doi: 10.1016/j.ejogrb.2003.10.032
– ident: e_1_2_6_13_1
  doi: 10.2214/ajr.158.3.1738998
– ident: e_1_2_6_2_1
  doi: 10.1097/00003081-199306000-00022
– ident: e_1_2_6_12_1
  doi: 10.1016/S0001-2998(88)80041-2
– ident: e_1_2_6_17_1
  doi: 10.1016/j.ajog.2005.06.019
– ident: e_1_2_6_11_1
  doi: 10.1046/j.1469-0705.1998.12010056.x
– ident: e_1_2_6_22_1
  doi: 10.1097/OGX.0b013e3181b8b0d6
– ident: e_1_2_6_20_1
  doi: 10.1016/j.fertnstert.2004.01.032
– ident: e_1_2_6_7_1
  doi: 10.1016/S0002-9378(98)70333-3
– ident: e_1_2_6_16_1
  doi: 10.1016/0002-9378(80)91107-2
– ident: e_1_2_6_19_1
  doi: 10.1111/j.1447-0756.1997.tb00867.x
SSID ssj0017918
Score 2.0361767
Snippet Aim The aim of this study was to identify factors that can predict the resistance to parenteral therapy in patients with tubo‐ovarian abscesses (TOA). Material...
The aim of this study was to identify factors that can predict the resistance to parenteral therapy in patients with tubo-ovarian abscesses (TOA). We conducted...
The aim of this study was to identify factors that can predict the resistance to parenteral therapy in patients with tubo-ovarian abscesses (TOA).AIMThe aim of...
SourceID proquest
pubmed
crossref
wiley
istex
SourceType Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 1019
SubjectTerms Abscess - microbiology
Abscess - physiopathology
Abscess - surgery
Abscess - therapy
Adult
Anti-Bacterial Agents - administration & dosage
Anti-Bacterial Agents - therapeutic use
antibiotic therapy
Case-Control Studies
Chlamydia Infections - drug therapy
Chlamydia Infections - epidemiology
Chlamydia trachomatis - drug effects
Chlamydia trachomatis - isolation & purification
Drug Resistance, Bacterial - drug effects
Fallopian Tube Diseases - microbiology
Fallopian Tube Diseases - physiopathology
Fallopian Tube Diseases - surgery
Fallopian Tube Diseases - therapy
Female
Humans
Infusions, Parenteral
Japan - epidemiology
Middle Aged
Ovarian Diseases - microbiology
Ovarian Diseases - physiopathology
Ovarian Diseases - surgery
Ovarian Diseases - therapy
pelvic inflammatory disease
Risk Factors
Severity of Illness Index
surgery
tubo-ovarian abscess
Title Evaluating the risk factors for developing resistance to parenteral therapy for tubo-ovarian abscess: A case-control study
URI https://api.istex.fr/ark:/67375/WNG-9RDGVJ47-C/fulltext.pdf
https://onlinelibrary.wiley.com/doi/abs/10.1111%2Fjog.12018
https://www.ncbi.nlm.nih.gov/pubmed/23509912
https://www.proquest.com/docview/1346582751
Volume 39
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1La9wwEB5CCiWX9JXHpg_UUkIuXrAlWd72FPLYsJAUQtLmEBCSrN1Dgl2y3tD2UPYnFPoP80s6Iz_alBRCL8aHsZGlmdE31sw3AG-Fty7n0kdSWR4JvEaGO3SGRA2SZGmWOSoUPjxKD07F6EyeLcD7tham5ofofriRZQR_TQZu7PRPIy8n_Ri3Lyr0jXlKvPm7xx11FLFuhjI49NJEuJs2rEIhi6d98tZe9ICm9ctdQPM2bg0bz_4jOG-HXOebXPRnle27b3-xOf7nNz2G5QaQsu1ag57Agi-ewsPD5sj9GXzfa_jAiwlDsMgoF501XXoYIl72u-yKYehOcBT1iFUlo9x2WjZ8e13l9TXIVzNb3sx_lNcYpZuC4dCoUuEd22YOd9Sb-c8me54F5tsVON3fO9k5iJqmDZET5DyTNJM-c7nyKs9tPubKjL0UXo6tcoLqBgxGYFZYbuLMY_SIIVHmExc7ERvHBV-FxaIs_Dqwsc25Ut6lXkmhVD7ghvqCxAOMClKfpT3YapdPu4bRnBprXOousiknOsxnD950op9rGo-7hDaDDnQS5uqC8t6U1J-OhnpwvDv8OBJK7_TgdaskGq2RjlhM4cvZVKO6IaRLlIx7sFZrT_e2hCM4G8QJDjvowL8HokcfhuFm4_6iz2EpCZ06KBfzBSxWVzP_EvFSZV8Fw_gFCScTDw
linkProvider Wiley-Blackwell
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9QwEB6VVgIuvB_L0yCEuGSlxE7sRVyqPnZZuotUtbAXZNmOdw9FCSpZBBxQfwIS_7C_hBnnQVsVCXGJcphEjjMz_sae-QbgmfDW5Tz1USotjwReI8MdOkOiBklUppSjQuHJNBvti_Esna3Aq7YWpuaH6DbcyDKCvyYDpw3pk1ZeLvoxrl_qAqwJBBoUem3uduRRxLsZCuHQTxPlbtbwCoU8nvbRU6vRGk3s1_Og5mnkGpae7avwoR10nXFy0F9Wtu--n-Fz_N-vugZXGkzK1mslug4rvrgBFyfNqftN-LHVUIIXC4Z4kVE6Omsa9TAEvexP5RXD6J0QKaoSq0pG6e305_DtdaHXtyBfLW15fPSz_IKBuimYQd-FDvclW2cOF9Xjo19NAj0L5Le3YH97a29jFDV9GyInyH8mmUq9crn0Ms9tPufSzH0qfDq30gkqHTAYhFlhuYmVxwASoyLlExc7ERvHBb8Nq0VZ-LvA5jbnUnqXeZkKKfMBN9QaJB5gYJB5lfXgRfv_tGtIzam3xkfdBTflQof57MHTTvRTzeRxntDzoASdhDk8oNQ3mer306Ee7G4O342F1Bs9eNJqiUaDpFMWU_hy-VmjviGqS2Qa9-BOrT7d2xKO-GwQJzjsoAR_H4gevx2Gm3v_LvoYLo32Jjt65_X0zX24nITGHZSa-QBWq8Olf4jwqbKPgpX8BimKFy4
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9QwEB6VVqq48H5seRmEEJeslNiOs3Cq2u6WhS6ootADkmU7zh5aJVXJIuCA-hOQ-If9Jcw4DygqEuIS5TCJHHtm_E088w3AY-Gty7n0kVSWRwKvkeEOnSFRgyRZmmWOCoV3Zun2npjuy_0leN7VwjT8EP0PN7KM4K_JwI_y4ncjr-bDGLev7AKsiBSRBCGi3Z47img3Qx0cumli3E1bWqGQxtM9emYzWqF5_Xwe0jwLXMPOM74MH7oxNwknB8NFbYfu6x90jv_5UVfgUotI2XqjQldhyZfXYHWnPXO_Dt-2WkLwcs4QLTJKRmdtmx6GkJf9qrtiGLsTHkVFYnXFKLmd1g3f3pR5fQny9cJWpyffq08YppuSGfRc6G6fsXXmcEs9PfnRps-zQH17A_bGW283tqO2a0PkBHnPJM2kz1yuvMpzmxdcmcJL4WVhlRNUOGAwBLPCchNnHsNHjIkyn7jYidg4LvhNWC6r0t8GVticK-Vd6pUUSuUjbqgxSDzCsCD1WTqAp93yaddSmlNnjUPdhzbVXIf5HMCjXvSo4fE4T-hJ0IFewhwfUOKbkvr9bKJHu5uTd1Oh9MYAHnZKotEc6YzFlL5afNSobojpEiXjAdxqtKd_W8IRnY3iBIcddODvA9HT15Nws_bvog9g9c3mWL96MXt5By4moWsH5WXeheX6eOHvIXaq7f1gIz8B3cIV3Q
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Evaluating+the+risk+factors+for+developing+resistance+to+parenteral+therapy+for+tubo-ovarian+abscess%3A+A+case-control+study&rft.jtitle=The+journal+of+obstetrics+and+gynaecology+research&rft.au=Mizushima%2C+Taichi&rft.au=Yoshida%2C+Hiroshi&rft.au=Ohi%2C+Yuka&rft.au=Ishikawa%2C+Masahiko&rft.date=2013-05-01&rft.pub=Blackwell+Publishing+Ltd&rft.issn=1341-8076&rft.eissn=1447-0756&rft.volume=39&rft.issue=5&rft.spage=1019&rft.epage=1023&rft_id=info:doi/10.1111%2Fjog.12018&rft.externalDBID=n%2Fa&rft.externalDocID=ark_67375_WNG_9RDGVJ47_C
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1341-8076&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1341-8076&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1341-8076&client=summon